Cleavage of HPV-16 E6/E7 mRNA Mediated by Modified 10-23 Deoxyribozymes

被引:15
|
作者
Reyes-Gutierrez, Pablo [1 ]
Alvarez-Salas, Luis M. [1 ]
机构
[1] CINVESTAV, Dept Genet & Biol Mol, Lab Terapia Gen, Mexico City 07360, DF, Mexico
关键词
HUMAN-PAPILLOMAVIRUS TYPE-16; CLEAVING DNA ENZYME; CERVICAL-CARCINOMA CELLS; LOCKED NUCLEIC-ACIDS; GENE-EXPRESSION; CULTURED-CELLS; CATALYTIC CORE; IN-VITRO; TAR RNA; INHIBITION;
D O I
10.1089/oli.2009.0193
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Deoxyribozymes (DXZs) are small oligodeoxynucleotides capable of mediating phosphodiester bond cleavage of a target RNA in a sequence-specific manner. These molecules are a new generation of artificial catalytic nucleic acids currently used to silence many disease-related genes. The present study describes a DXZ (Dz1023-434) directed against the polycistronic mRNA from the E6 and E7 genes of human papillomavirus type 16 (HPV-16), the main etiological agent of cervical cancer. Dz1023-434 showed efficient cleavage against a bona fide antisense window at nt 410-445 within HPV-16 E6/E7 mRNA even in low [Mg2+] conditions. Using a genetic analysis as guidance, we introduced diverse chemical modifications within Dz1023-434 catalytic core to produce a stable locked nucleic acid (LNA)-modified DXZ (Dz434-LNA) with significant cleavage activity of full E6/E7 transcripts. Cell culture testing of Dz434-LNA produced a sharp decrement of E6/E7 mRNA levels in HPV-16-positive cells resulting in decreased proliferation and considerable cell death in a specific and dose-dependent manner. No significant effects were observed with inactive or scrambled control DXZs nor from using HPV-negative cells, suggesting catalysis-dependent effect and high specificity. The biological effects of Dz434-LNA suggest a potential use for the treatment of cervical cancer.
引用
收藏
页码:233 / 242
页数:10
相关论文
共 50 条
  • [1] Viral recombinant vaccines to the E6 and E7 antigens of HPV-16
    He, Z
    Wlazlo, AP
    Kowalczyk, DW
    Cheng, J
    Xiang, ZQ
    Giles-Davis, W
    Ertl, HCJ
    VIROLOGY, 2000, 270 (01) : 146 - 161
  • [2] Ribozyme-mediated inhibition of HPV-16 E6/E7 immortalization of human keratinocytes.
    Alvarez, LM
    Cullinan, AE
    Siwkowski, A
    Hampel, A
    DiPaolo, JA
    EUROPEAN JOURNAL OF CANCER, 1998, 34 : S37 - S37
  • [3] 云南HPV-16型E6、E7基因的突变分析
    张晓琳
    刘峰
    姚月婷
    李亚东
    周竞贤
    易力
    姚宇峰
    俞建昆
    微生物学杂志, 2014, 34 (02) : 17 - 23
  • [4] CONSERVATION OF HPV-16 E6/E7 ORF SEQUENCES IN A CERVICAL-CARCINOMA
    CONE, RW
    MINSON, AC
    SMITH, MR
    MCDOUGALL, JK
    JOURNAL OF MEDICAL VIROLOGY, 1992, 37 (02) : 99 - 107
  • [5] Inhibition of HPV-16 E6/E7 immortalization of normal keratinocytes by hairpin ribozymes
    Alvarez-Salas, LM
    Cullinan, AE
    Siwkowski, A
    Hampel, A
    DiPaolo, JA
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (03) : 1189 - 1194
  • [6] In vitro antigene therapy targeting HPV-16 E6 and E7 in cervical carcinoma
    Madrigal, M
    Janicek, MF
    Sevin, BU
    Perras, J
    Estape, R
    Penalver, M
    Averette, HE
    GYNECOLOGIC ONCOLOGY, 1997, 64 (01) : 18 - 25
  • [7] HPV-16 oncogenes E6 and E7 are mutagenic in normal human oral keratinocytes
    Xuan Liu
    Simon Han
    Marcel A Baluda
    No-Hee Park
    Oncogene, 1997, 14 : 2347 - 2353
  • [8] Analysis of oncogenes E6 and E7 variants in 78 women infected with HPV-16
    Coste-Burel, M
    Besse, B
    Papy, K
    Lopes, P
    Laboisse, C
    Imbertmarcille, BM
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2004, 24 : S101 - S101
  • [9] HPV-16 oncogenes E6 and E7 are mutagenic in normal human oral keratinocytes
    Liu, X
    Han, S
    Baluda, MA
    Park, NH
    ONCOGENE, 1997, 14 (19) : 2347 - 2353
  • [10] The relationship between cytokines and HPV-16, HPV-16 E6, E7, and high-risk HPV viral load in the uterine cervix
    Song, Seung-Hun
    Lee, Jae-Kwan
    Seok, Oye-Sun
    Saw, Ho-Suk
    GYNECOLOGIC ONCOLOGY, 2007, 104 (03) : 732 - 738